
As a result, the new rules will not go into effect for the time being. The rules, which limit the number of continuing applications to two and the number of claims per application to 25, including no more than five independent claims, have been strongly opposed by patent practitioners and industry leaders. According to IP Law 360, GlaxoSmithKline filed the final complaint against the USPTO, alleging that the rules were introduced without “proper legal authority” and that the new rules were “vague, arbitrary and capricious”. In a response submitted after the hearing, the USPTO stated that they will be standing by their new regulations.

12/08/2007 \| Posted in: Intellectual Property and Patents

Featured news Health messages required on alcoholic beverages from 24 February 2009
Consumers have become accustomed to the health warnings found on cigarettes and other tobacco products. Similar health warnings will soon have to be placed on alcoholic beverages, including beer.

Featured office: Mozambique
Inquiry: (+258) 21 333 200

Featured person:
Dohmen, Danie
Partner
Patent Attorney
Tel: +27 (0) 12 432 6201
Email

Adams & Adams is a B-BBEE LEVEL 4 Contributor

View programme

The firm practises directly in several Southern African countries and through long-established associates in others.